Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

PHASE4UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG

Linagliptin

Linagliptin dosed 5 mg as add on therapy to an existing metformin therapy

DRUG

Glimepiride

Glimepiride 1-4mg (individually dosed) as add on therapy to an existing metformin therapy

Trial Locations (1)

RECRUITING

ikfe GmbH, Mainz